12:00 AM
May 04, 2009
 |  BC Week In Review  |  Clinical News  |  Regulatory

Tamiflu oseltamivir regulatory update

In response to requests from the U.S. Centers for Disease Control and Prevention (CDC), FDA issued an Emergency Use Authorization (EUA) for Tamiflu oseltamivir to make the drug available to public health and medical personnel to respond to the swine flu virus under certain circumstances. The EUA...

Read the full 214 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >